MGP
REGN icon

Metis Global Partners’s Regeneron Pharmaceuticals REGN Stock Holding History

Metis Global Partners’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.52M Sell
2,439
-2,009
-45% -$1.37M 0.03% 366
2026
Q1 		$3.44M Sell
4,448
-383
-8% -$293K 0.08% 199
2025
Q4 		$3.73M Sell
4,831
-380
-7% -$258K 0.09% 195
2025
Q3 		$2.93M Sell
5,211
-286
-5% -$162K 0.07% 241
2025
Q2 		$2.89M Sell
5,497
-810
-13% -$452K 0.07% 231
2025
Q1 		$4M Buy
6,307
+794
+14% +$546K 0.11% 159
2024
Q4 		$3.93M Buy
5,513
+169
+3% +$142K 0.12% 143
2024
Q3 		$5.62M Buy
5,344
+90
+2% +$100K 0.18% 96
2024
Q2 		$5.52M Buy
5,254
+21
+0.4% +$20.4K 0.19% 86
2024
Q1 		$5.04M Buy
5,233
+7
+0.1% +$6.66K 0.18% 96
2023
Q4 		$4.59M Sell
5,226
-244
-4% -$201K 0.18% 101
2023
Q3 		$4.5M Buy
5,470
+694
+15% +$545K 0.22% 93
2023
Q2 		$3.43M Buy
4,776
+83
+2% +$64K 0.18% 109
2023
Q1 		$3.86M Buy
4,693
+600
+15% +$453K 0.25% 83
2022
Q4 		$2.95M Buy
4,093
+1,139
+39% +$840K 0.26% 87
2022
Q3 		$2.03M Buy
2,954
+98
+3% +$61.7K 0.33% 61
2022
Q2 		$1.69M Buy
2,856
+788
+38% +$512K 0.27% 83
2022
Q1 		$1.44M Buy
2,068
+765
+59% +$484K 0.17% 112
2021
Q4 		$822K Buy
+1,303
New +$801K 0.23% 99

Other funds holding REGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dodge & Cox
Dodge & Cox San Francisco, California $191B AUM 17.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Metis Global Partners's REGN Position: Q2 2026 in Review

Metis Global Partners reduced its Regeneron Pharmaceuticals (REGN) stake by 45% in Q2 2026, selling an estimated $1.37M and leaving 2,439 shares worth $1.52M. The position accounts for 0.03% of the portfolio, ranked #366.

Metis Global Partners first reported a position in REGN in Q4 2021 and has held it in 19 quarters since. The position peaked at $5.62M in Q3 2024. 1,333 funds tracked by Wall St. Rank hold REGN as of Q2 2026.

  • Metis Global Partners held 2,439 shares of Regeneron Pharmaceuticals worth $1.52M as of Q2 2026.
  • Metis Global Partners sold 2,009 Regeneron Pharmaceuticals shares in Q2 2026, an estimated $1.37M.
  • Regeneron Pharmaceuticals made up 0.03% of Metis Global Partners's portfolio in Q2 2026, its #366 holding.
  • Metis Global Partners first reported a position in Regeneron Pharmaceuticals in Q4 2021 and has held it in 19 quarters since.
  • Metis Global Partners's Regeneron Pharmaceuticals position peaked at $5.62M in Q3 2024.
  • 1,333 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2026.

Based on Metis Global Partners's 13F filing for Q2 2026, filed 10 Aug 2026.